MicroPort NeuroScientific Corporation (HKG:2172)

Market Cap	6.61B +1.1%
Revenue (ttm)	807.00M -4.9%
Net Income	223.08M -9.5%
EPS	0.39 -8.9%
Shares Out	575.97M
PE Ratio	29.70
Forward PE	21.97
Dividend	0.22 (1.92%)
Ex-Dividend Date	n/a

Volume	9,773,396
Average Volume	3,344,830
Open	11.19
Previous Close	11.18
Day's Range	10.93 - 11.86
52-Week Range	9.02 - 19.06
Beta	-0.10
RSI	50.77
Earnings Date	Mar 25, 2026

About MicroPort NeuroScientific

MicroPort NeuroScientific Corporation provides neuro-interventional medical devices. The company offers NUMEN, a coil embolization system; NUMEN FR, a coil detachment system; NUMEN Silk, a 3D electronically detachable coil; Numen Lighting, a coil embolization system; Numen Nest, a detachable coil; NuFairy absorbable coil embolization system; Tubridge, a flow-diverting stent; Tubridge Plus, a flow-diverting stent; WILLIS, a intracranial stent graft system; Comaneci, a embolization assist device; and Rebridge, an intracranial visualized stent for...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2004
• Employees: 522
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2172

Financial Performance

In 2024, MicroPort NeuroScientific's revenue was 761.76 million, an increase of 14.44% compared to the previous year's 665.62 million. Earnings were 254.17 million, an increase of 74.63%.

Financial numbers in CNY